Chemours Files 8-K for Regulation FD Disclosure
Ticker: CC · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulation-fd
Related Tickers: CC
TL;DR
Chemours filed a standard 8-K, no major news.
AI Summary
On March 6, 2024, The Chemours Company filed an 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.
Why It Matters
This filing indicates Chemours is adhering to its disclosure obligations with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing that does not disclose new material information or significant risks.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is March 6, 2024.
What is the principal executive office address of The Chemours Company?
The address of the principal executive offices is 1007 Market Street, Wilmington, Delaware 19801.
What is the IRS Employer Identification Number for The Chemours Company?
The IRS Employer Identification Number for The Chemours Company is 46-4845564.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-03-06 21:28:01
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- d806416d8k.htm (8-K) — 24KB
- d806416dex991.htm (EX-99.1) — 17KB
- g806416g0307014148284.jpg (GRAPHIC) — 3KB
- g806416g0307072546330.jpg (GRAPHIC) — 6KB
- g806416g0307072546592.jpg (GRAPHIC) — 4KB
- 0001193125-24-061056.txt ( ) — 183KB
- cc-20240306.xsd (EX-101.SCH) — 3KB
- cc-20240306_lab.xml (EX-101.LAB) — 17KB
- cc-20240306_pre.xml (EX-101.PRE) — 11KB
- d806416d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press release dated March 6, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Matthew S. Abbott Matthew S. Abbott Interim Chief Financial Officer Date: March 7, 2024